ClinicalTrials.gg
CompletedNCT03642275iCardia4HFUpdated Oct 7, 2026Results posted

Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure

An interventional study of iCardia4HF in Heart Failure, sponsored by University of Illinois at Chicago. Completed at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Treatment

How we know

Updated Oct 7, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 2,159 studies in Heart Failure with a site in United States — 346 open to participants now, 439 under way, 27 of them phase 3. Heart Failure · United States.

Enrollment
1,131st of 1,602
27 · median 66
Started
2019
with 91 others
No phase
887 of 2,159
159 open now
Registered
1,293rd of 2,159
by date

Among the 2,159 studies in Heart Failure with a site in United States, this one is the 1,131st largest by enrollment of the 1,602 interventional ones that give a count, is one of 92 that started in 2019, is one of 887 with no phase, and was the 1,293rd registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

346 of the 2,159 studies in Heart Failure with a site in United States are open now. Recruiting first, the newest first:

341 more — sign in →

All 346 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 40 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,159 studies in Heart Failure with a site in United States, or all of them as a file.
02

Study summary

Approximately 6.5 million people have heart failure (HF) in the United States, and 960,000 new cases are reported each year. HF is one of the most common hospital diagnosis among older adults. About 40% of patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 80% of the costs of HF management. This pilot study aims to assess the feasibility, acceptability, and preliminary efficacy of a patient-centered mobile health (mHealth) technology intervention in older adults with chronic heart failure.

Read the detailed description

This is a single site, two-arm, pilot randomized controlled trial that aims to examine the feasibility, acceptability and preliminary efficacy of a mobile phone-based intervention compared to usual care in older adult patients with HF (≥50 years). Forty (n=40) patients from the University of Illinois Hospital \& Health Sciences system will be enrolled in the study, randomly assigned to the intervention or usual care group, and followed for 60 days. Patients in the intervention group will receive the Heart Failure Health Storylines mobile app developed by Self Care Catalysts in collaboration with the Heart Failure Society of America, three connected health devices from Fitbit and Nokia that interface with the mobile app, and tailored text-messages targeting health beliefs, self-care efficacy, and knowledge about HF. The control group will receive standard care which involves patient education and outpatient follow up with physical and laboratory examinations as needed. The primary study outcome is change in self-care and quality of life. Secondary outcomes include hospital re-admissions and emergency room visits.

03

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • heart failure
  • mHealth
  • smartphone
  • wearable electronic devices
  • text messaging
  • self-management
  • self-care
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inpatients or outpatients with a diagnosis of HF as defined by the International Classification of Diseases (ICD-10) codes
  • Stage C, I, II or III
  • ≥ 40 years of age
  • Own a smartphone with text-messaging and internet plan
  • Ability to speak and read English
  • Live within 30 miles from UI Health

Exclusion criteria

Exclusion Criteria:

  • On an active waiting list for implanted ventricular assist device or heart transplant
  • Advanced renal disease (dialysis or creatinine >4.0mg/dL)
  • End-stage HF (hospice candidate)
  • Active cancer
  • Individuals who are not their own primary caregiver
  • Discharge to a setting other than home
  • Patients with baseline (MoCA) score of \< 22
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    iCardia4HF

    Participants will be using a heart failure mobile app, wearable activity tracking device, Bluetooth-enabled blood pressure monitor and weight scale for self-monitoring, and receive tailored text-messages about self-care.

    Behavioral: iCardia4HF

  • No intervention
    Control Group

    Participants assigned to the usual care group will receive standard medical care, which includes nurse-led patient education about HF self-care before discharge, and follow-up visits at the UI Health, outpatient Heart Failure program.

Interventions

  • BehavioraliCardia4HF

    Participants in the intervention group will receive the Heart Failure Health Storylines mobile app, three connected health devices that interface with the app (Fitbit Charge 2 activity tracker, and FDA-approved Nokia BP monitor and Cardio Body weight scale), and a program of tailored self-care text-messages, in addition to usual care. Participants will be asked to use the app and devices to record and self-monitor their daily symptoms, blood pressure, weight, and physical activity.

06

What researchers measure

Primary outcomes

  1. Mean Change in Self-care at 30 and 60 Days

    Self-care was measured with the Self-Care Heart Failure Index (SCHFI version 7.2) which includes 4 subscales: maintenance, symptom perception, management, and self-efficacy. Each scale is scored separately. Standardized scores in each scale range from 0 to 100. Higher scores indicate better self-care. Note: According to the original protocol, we had planned to use SCHFI version 6.2 which had 3 subscales (maintenance, management, and self-efficacy). However, a newer version (SCHFI v 7.2) became available before the start of the study, and we decided to use the new version.

    Time frame: Baseline, 30 and 60 days

Secondary outcomes

  1. Change From Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 Days

    Self-reported Health-related Quality of Life was measured with the Kansas City Cardiomyopathy Questionnaire (KCCQ-12). KCCQ has four domains: Physical limitation, Symptom frequency, Quality of life, and Social Limitation. An overall summary score is calculated as the average of all four domains. Scores in each domain range from a 0-to-100 points. Lower scores represent worse health status and higher scores indicate better health status. The results below present the mean difference from baseline to 30 days and to 60 days. Positive numbers indicate improvement in health status scores, while negative numbers indicate worsening of health status scores from baseline.

    Time frame: Baseline, 30 and 60 days

  2. Hospitalizations

    Number of unplanned hospitalizations due to any cause during the study (recorded from the electronic medical record and patient self-reports)

    Time frame: 60 days

  3. ER Visits

    Emergency room visits (tracked from the electronic medical record and patient self-reports)

    Time frame: 60 days

07

Results

Posted Oct 7, 2026

Participant flow

Participant flow — Overall Study
MilestoneiCardia4HFControl Group
Started1314
Completed1114
Not completed20
Withdrew: Lost to follow-up10
Withdrew: Ineligible, admitted to a nursing home10

Outcome measures

PrimaryMean Change in Self-care at 30 and 60 Days

Self-care was measured with the Self-Care Heart Failure Index (SCHFI version 7.2) which includes 4 subscales: maintenance, symptom perception, management, and self-efficacy. Each scale is scored separately. Standardized scores in each scale range from 0 to 100. Higher scores indicate better self-care. Note: According to the original protocol, we had planned to use SCHFI version 6.2 which had 3 subscales (maintenance, management, and self-efficacy). However, a newer version (SCHFI v 7.2) became available before the start of the study, and we decided to use the new version.

Time frame:
Baseline, 30 and 60 days
Reported as:
Mean · score on a scale
Mean Change in Self-care at 30 and 60 Days
score on a scaleiCardia4HFControl Group
Maintenance at 30 Days6.14 ± 15.39-3.39 ± 18.16
Maintenance at 60 Days6.36 ± 15.343.75 ± 12.51
Symptom Perception at 30 Days6.82 ± 10.046.73 ± 22.61
Symptom Perception at 60 Days7.83 ± 9.854.37 ± 10.93
Management at 30 Days5.19 ± 14.59-7.64 ± 14.07
Management at 60 Days5.19 ± 20.141.19 ± 11.77
self-efficacy at 30 Days5.68 ± 13.92-1.10 ± 12.20
self-efficacy at 60 Days7.50 ± 17.21-2.50 ± 12.33
SecondaryChange From Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 Days

Self-reported Health-related Quality of Life was measured with the Kansas City Cardiomyopathy Questionnaire (KCCQ-12). KCCQ has four domains: Physical limitation, Symptom frequency, Quality of life, and Social Limitation. An overall summary score is calculated as the average of all four domains. Scores in each domain range from a 0-to-100 points. Lower scores represent worse health status and higher scores indicate better health status. The results below present the mean difference from baseline to 30 days and to 60 days. Positive numbers indicate improvement in health status scores, while negative numbers indicate worsening of health status scores from baseline.

Time frame:
Baseline, 30 and 60 days
Reported as:
Mean · score on a scale
Change From Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 Days
score on a scaleiCardia4HFControl Group
Mean Change in Physical Limitation at 30 Days20.08 ± 27.44-1.64 ± 36.51
Mean Change in Symptom Frequency at 30 Days6.25 ± 36.385.62 ± 28.90
Mean Change in Quality of Life at 30 Days7.95 ± 31.763.53 ± 20.99
Mean Change in Social Limitation at 30 Days14.96 ± 31.34-5.45 ± 25.71
Mean Change in Overall Summary Score at 30 Days12.61 ± 23.820.12 ± 22.80
Mean Change in Physical Limitation at 60 Days25.38 ± 22.8612.50 ± 28.50
Mean Change in Symptom Frequency at 60 Days11.93 ± 29.183.13 ± 26.86
Mean Change in Quality of Life at 60 Days11.36 ± 24.6611.61 ± 20.49
Mean Change in Social Limitation at 60 Days13.07 ± 31.07-5.36 ± 32.46
Mean Change in Overall Summary Score at 60 Days15.74 ± 22.935.47 ± 21.81
SecondaryHospitalizations

Number of unplanned hospitalizations due to any cause during the study (recorded from the electronic medical record and patient self-reports)

Time frame:
60 days
Reported as:
Number · number of hospitalizations
Hospitalizations
number of hospitalizationsiCardia4HFControl Group
Hospitalizations42
SecondaryER Visits

Emergency room visits (tracked from the electronic medical record and patient self-reports)

Time frame:
60 days
Reported as:
Number · Number of ER visits
ER Visits
Number of ER visitsiCardia4HFControl Group
ER Visits22

Adverse events

Collected over 60 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
iCardia4HF0/11 (0%)3/11 (27.3%)0/11 (0%)
Control Group0/14 (0%)1/14 (7.1%)0/14 (0%)
Most frequent serious events
Most frequent serious events
EventiCardia4HFControl Group
Acute Decompensated Chronic Heart FailureCardiac disorders1/110/14
Internal HemorrhoidsGastrointestinal disorders1/110/14
Armpit abscessInfections and infestations1/110/14
branched retinal artery occlusionEye disorders1/110/14
Diarrhea with Uncertain CauseGastrointestinal disorders1/110/14
Chest painCardiac disorders0/111/14

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)iCardia4HFControl GroupTotal
<=18 years000
Between 18 and 65 years81220
>=65 years325
Age, Continuous
Age, Continuous(years)iCardia4HFControl GroupTotal
Mean55.4 ± 9.1756.4 ± 7.856 ± 8.3
Sex: Female, Male
Sex: Female, Male(Participants)iCardia4HFControl GroupTotal
Female6511
Male5914
Race (NIH/OMB)
Race (NIH/OMB)(Participants)iCardia4HFControl GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American101323
White112
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)iCardia4HFControl GroupTotal
United States111425
08

Study locations

1 site
  • University of Illinois Hospital & Health Sciences System
    Chicago, Illinois 60612, United States
09

References and documents

Publications

  • Kitsiou S, Gerber BS, Buchholz SW, Kansal MM, Sun J, Pressler SJ. Patient-Centered mHealth Intervention to Improve Self-Care in Patients With Chronic Heart Failure: Phase 1 Randomized Controlled Trial. J Med Internet Res. 2025 Jan 15;27:e55586. doi: 10.2196/55586. PubMed 39813671 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2019 to primary completion in Feb 2020, 12 months.

Results were first posted in Oct 2026, 6 years 7 months after primary completion.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's 12 months is below that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2018
First posted
Aug 22, 2018
StartActual
Jan 21, 2019
Primary completionActual
Feb 15, 2020
CompletionActual
Feb 15, 2021
Results first posted
Oct 7, 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 7, 2026
Primary outcomes
1 edited, 1 removed
What changed in the outcomes
  • EditedMean Change from Baseline in Self-care at 30 and 60 daysDaysTime frame: Baseline, 30 and 60 days
  • RemovedChange from Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 daysTime frame: Baseline, 30 and 60 days
Oct 7, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 39813671 ↗
Oct 7, 2026
Secondary outcomes
1 edited, 1 added, 1 description edited
What changed in the outcomes
  • EditedER visitsVisitsTime frame: 60 days
  • AddedChange From Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 DaysTime frame: Baseline, 30 and 60 days
  • DescriptionHospitalizations: how it is measured was reworded
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Results posted
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 39813671 ↗
    Primary outcomes 1 edited, 1 removed
    What changed in the outcomes
    • EditedMean Change from Baseline in Self-care at 30 and 60 daysDaysTime frame: Baseline, 30 and 60 days
    • RemovedChange from Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 daysTime frame: Baseline, 30 and 60 days
    Secondary outcomes 1 edited, 1 added, 1 description edited
    What changed in the outcomes
    • EditedER visitsVisitsTime frame: 60 days
    • AddedChange From Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 DaysTime frame: Baseline, 30 and 60 days
    • DescriptionHospitalizations: how it is measured was reworded
    + 4 other changes: verification date, responsible party, registry notes and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03642275
Responsible party
Spyros Kitsiou (Associate Professor, University of Illinois at Chicago) — Principal investigator
First posted
Aug 22, 2018
Start date
Jan 21, 2019
Primary completion
Feb 15, 2020
Completion
Feb 15, 2021
Results posted
Oct 7, 2026
Last update
Oct 7, 2026

Study contacts

Spyros Kitsiou, PhD
principal investigator · University of Illinois at Chicago

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion